X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with ALEMBIC PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs ALEMBIC PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB ALEMBIC PHARMA UNICHEM LAB/
ALEMBIC PHARMA
 
P/E (TTM) x 22.1 26.6 83.0% View Chart
P/BV x 2.3 6.1 38.3% View Chart
Dividend Yield % 0.8 0.8 105.3%  

Financials

 UNICHEM LAB   ALEMBIC PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
ALEMBIC PHARMA
Mar-16
UNICHEM LAB/
ALEMBIC PHARMA
5-Yr Chart
Click to enlarge
High Rs334792 42.2%   
Low Rs174443 39.3%   
Sales per share (Unadj.) Rs146.9167.0 88.0%  
Earnings per share (Unadj.) Rs11.938.2 31.2%  
Cash flow per share (Unadj.) Rs16.242.0 38.5%  
Dividends per share (Unadj.) Rs2.004.00 50.0%  
Dividend yield (eoy) %0.80.6 121.5%  
Book value per share (Unadj.) Rs105.184.9 123.8%  
Shares outstanding (eoy) m90.84188.52 48.2%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.73.7 46.8%   
Avg P/E ratio x21.416.2 132.0%  
P/CF ratio (eoy) x15.714.7 106.7%  
Price / Book Value ratio x2.47.3 33.2%  
Dividend payout %16.810.5 160.4%   
Avg Mkt Cap Rs m23,073116,383 19.8%   
No. of employees `0005.7NA-   
Total wages/salary Rs m2,5584,214 60.7%   
Avg. sales/employee Rs Th2,352.5NM-  
Avg. wages/employee Rs Th450.9NM-  
Avg. net profit/employee Rs Th190.4NM-  
INCOME DATA
Net Sales Rs m13,34631,487 42.4%  
Other income Rs m19255 348.3%   
Total revenues Rs m13,53831,542 42.9%   
Gross profit Rs m1,63910,060 16.3%  
Depreciation Rs m390722 54.0%   
Interest Rs m2937 78.3%   
Profit before tax Rs m1,4129,356 15.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-4-2 246.7%   
Extraordinary Inc (Exp) Rs m-350-   
Tax Rs m2932,160 13.5%   
Profit after tax Rs m1,0807,194 15.0%  
Gross profit margin %12.331.9 38.4%  
Effective tax rate %20.723.1 89.8%   
Net profit margin %8.122.8 35.4%  
BALANCE SHEET DATA
Current assets Rs m5,97915,066 39.7%   
Current liabilities Rs m2,4327,674 31.7%   
Net working cap to sales %26.623.5 113.2%  
Current ratio x2.52.0 125.2%  
Inventory Days Days6367 94.2%  
Debtors Days Days6041 148.6%  
Net fixed assets Rs m6,4038,237 77.7%   
Share capital Rs m182377 48.2%   
"Free" reserves Rs m9,29315,416 60.3%   
Net worth Rs m9,54816,005 59.7%   
Long term debt Rs m2300-   
Total assets Rs m12,84324,594 52.2%  
Interest coverage x50.0255.2 19.6%   
Debt to equity ratio x00-  
Sales to assets ratio x1.01.3 81.2%   
Return on assets %8.629.4 29.4%  
Return on equity %11.344.9 25.2%  
Return on capital %14.358.7 24.4%  
Exports to sales %29.255.7 52.4%   
Imports to sales %6.310.4 60.8%   
Exports (fob) Rs m3,90017,551 22.2%   
Imports (cif) Rs m8473,283 25.8%   
Fx inflow Rs m4,35617,811 24.5%   
Fx outflow Rs m1,1625,318 21.9%   
Net fx Rs m3,19412,493 25.6%   
CASH FLOW
From Operations Rs m1,1199,304 12.0%  
From Investments Rs m-853-3,105 27.5%  
From Financial Activity Rs m-334-1,959 17.1%  
Net Cashflow Rs m-684,240 -1.6%  

Share Holding

Indian Promoters % 50.1 74.1 67.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 2.9 520.7%  
FIIs % 3.0 9.1 33.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 13.9 228.1%  
Shareholders   20,176 49,328 40.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   CADILA HEALTHCARE  TTK HEALTHCARE  ORCHID PHARMA LTD  BIOCON LTD  SUVEN LIFE  

Compare UNICHEM LAB With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Red; Auto Stocks Witness Selling(01:30 pm)

After opening the day flat, share markets in India continued to witness selling pressure and are currently trading in red. Sectoral indices are trading on a mixed note with stocks in the metals sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Aug 21, 2017 02:49 PM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB - STERLING BIOTECH COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS